Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,080,642
-$155,246 QoQ
Shares Held
4,255
-15.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#2,953
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stockman Wealth Management, Inc. holds $51,758,933 across 8 Drug Manufacturers - General names. JNJ ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
169,661 | $21,801,438 | |
| 2 | GSK |
GSK plc
|
264,689 | $13,874,997 | |
| 3 | PFE |
Pfizer Inc
|
465,614 | $11,211,985 | |
| 4 | LLY |
ELI LILLY & Co
|
1,454 | $1,743,971 | |
| 5 | AZN |
Astrazeneca PLC
|
5,841 | $1,107,570 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
4,255 | $1,080,642 | |
| 7 | ABBV |
AbbVie Inc.
|
2,687 | $676,156 | |
| 8 | AMGN |
Amgen Inc
|
724 | $262,174 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,080,642 | 4,255 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,235,888 | 5,056 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,288,056 | 6,224 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,189,469 | 6,415 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,014,412 | 6,641 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,163,201 | 7,014 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,034,466 | 7,153 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,210,426 | 7,469 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,087,868 | 7,443 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,247,328 | 7,885 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,334,014 | 8,511 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,325,899 | 8,513 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,570,288 | 9,487 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,636,335 | 10,557 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,945,799 | 11,015 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,746,318 | 10,690 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,889,416 | 10,644 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,837,697 | 10,369 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,024,955 | 11,837 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,921,365 | 11,897 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,954,804 | 11,866 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,946,725 | 11,845 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,893,281 | 12,030 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,794,450 | 12,053 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,707,670 | 12,143 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,514,551 | 11,550 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||